We have FTD and rolling BLA review given to us for
Post# of 148319
In addition , first part given to FDA in March , so reviewed by now.
Second part clinical , they must review most information for us to have dose for treatment ..
I think like some others that it is a good chance for approval April-May , but of course no one know for sure with FDA.
All imo.